Donald Prater takes over FDA Human Foods Program on an acting basis

The FDA has tapped Donald A. Prater, DVM, to serve as acting deputy commissioner for food, a role that puts him atop the agency’s Human Foods Program at a moment of broader leadership turnover. FDA’s own leadership page says Prater is now responsible for all FDA nutrition and food safety activities within the Human Foods Program, including authority over operations, resources, policy initiatives, and major response activities involving human foods. (fda.gov)

The move comes less than two years after FDA formally launched its unified Human Foods Program as part of a major reorganization meant to consolidate food-related functions that had previously been split across the Center for Food Safety and Applied Nutrition, the Office of Food Policy and Response, and parts of the former Office of Regulatory Affairs, now the Office of Inspections and Investigations. That restructuring, approved in 2024, was designed to create a clearer line of authority over human food oversight. (fda.gov)

Prater is a longtime FDA insider with unusually direct ties to veterinary medicine. FDA says he earned his DVM from the Virginia-Maryland Regional College of Veterinary Medicine, joined the Center for Veterinary Medicine in 1999 as a veterinary medical officer, and later held roles including associate commissioner for imported food safety, acting director of CFSAN, and principal deputy associate commissioner for food. In other words, he arrives with experience that spans animal health, imported food oversight, food safety policy, and the mechanics of FDA reorganization itself. (fda.gov)

Industry reporting adds another layer: Food Safety Magazine and Food Dive both reported in mid-May that Prater was stepping in after Kyle Diamantas moved from leading the Human Foods Program to acting FDA commissioner. Food Dive also noted that the Human Foods Program oversees roughly 80% of the U.S. food supply, underscoring the scale of the portfolio Prater is inheriting. AFDO’s May 19 e-newsletter flagged the appointment as a notable development for the food regulatory community, suggesting the move was quickly recognized across industry and state-federal regulatory circles. (food-safety.com)

There does not appear to be much public expert commentary yet that directly critiques or interprets Prater’s appointment itself. What is clearer is the institutional context: Prater has been closely tied to the Human Foods Program’s build-out, and outside legal and policy observers have described the 2024 reorganization as a significant attempt to modernize FDA food oversight while stopping short of folding the Center for Veterinary Medicine into the new human foods structure. That distinction matters. CVM still regulates animal food, including pet food, while the Human Foods Program focuses on human food oversight. (cov.com)

Why it matters: For veterinary professionals, this is leadership news worth watching because Prater understands FDA from both the veterinary and food sides. His background may make him a more fluent bridge between human food safety policy and adjacent animal health issues, especially where imported ingredients, feed controls, foodborne hazards, or One Health-style coordination overlap. But it’s also important not to overread the appointment: veterinarians concerned with pet food recalls, animal feed compliance, or CVM policy should remember that those authorities remain centered in CVM, even as the Human Foods Program works more closely with inspections, labs, and outbreak response functions across FDA. (fda.gov)

There’s also a practical signal here for the veterinary business audience. A veterinarian now leads FDA’s human foods arm on an acting basis during a period of policy pressure around food ingredients, nutrition, and safety modernization. Even if the immediate effect on companion animal practice is indirect, leadership choices at FDA can shape enforcement tempo, intercenter collaboration, and how quickly the agency responds to food-related safety events that may spill into animal health conversations or pet parent concerns. That’s especially relevant for veterinarians fielding questions about recalls, contaminated ingredients, or the interface between human and animal food supply chains. (fooddive.com)

What to watch: The next key question is whether Prater remains in the acting role for an extended period and whether FDA signals any new priorities for the Human Foods Program under his leadership, particularly around outbreak response, imported food oversight, ingredient policy, and coordination with other FDA centers as the post-2024 reorganization matures. (fda.gov)